Hi, today we are going to talk about ArQule and its current landscape. ArQule shares are in evidence today as was unveiled that the company it's going to be acquired by the American multinational pharmaceutical company Merck & Co., Inc. for $20 per share in cash, totalizing a deal of $2.7 billion. In this season of Mergers and Acquisitions, the Merck & Co. move is...
this is like Msoft Google in the tech during early days with ARQULE science and projects in the pipeline big boys should take a look into whats brewing on PRECISION MEDICINE
Still in trade, watching how this value channel is holding up since gap up. Already taken profit at swing high given the amount of move.
Wedge Breakout List added. Great volume runner as well.
Arql ( Arqule) Market cap : 345 Mil( 22 may) Sector : healthcare Industry : biotechnology Fair Value : 3,57